22 results
Keyword Docetaxel Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Ogivri
Date of authorisation: 12/12/2018,
, 
, Revision: 2, Authorised, Last updated: 05/08/2019
medicines: with paclitaxel or docetaxel, or with another type of medicine … -
List item
Human medicine European public assessment report (EPAR): Tecentriq
Date of authorisation: 20/09/2017,, Revision: 6, Authorised, Last updated: 23/10/2019
Tecentriq is more effective than docetaxel (another cancer medicine … average while those given docetaxel lived for 10 months. In a … 10 months for patients on docetaxel. In another main study of … -
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
Date of authorisation: 16/05/2018,, , Revision: 6, Authorised, Last updated: 29/11/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Opdivo
Date of authorisation: 19/06/2015,, Revision: 28, Authorised, Last updated: 28/10/2019
compared with 9.4 months with docetaxel. For squamous NSCLC, a study … months in patients given docetaxel. Supportive information was … -
List item
Human medicine European public assessment report (EPAR): Ontruzant
Date of authorisation: 15/11/2017,, , Revision: 4, Authorised, Last updated: 07/10/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Trazimera
Date of authorisation: 26/07/2018,, , Revision: 3, Authorised, Last updated: 07/10/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Herzuma
Date of authorisation: 08/02/2018,, , Revision: 6, Authorised, Last updated: 14/08/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Date of authorisation: 17/07/2015,, Revision: 24, Authorised, Last updated: 11/12/2019
another cancer medicine called docetaxel (around 8 months) and the … -
List item
Human medicine European public assessment report (EPAR): Zykadia
Date of authorisation: 06/05/2015,, Revision: 12, Authorised, Last updated: 26/08/2019
-
List item
Human medicine European public assessment report (EPAR): Akynzeo
Date of authorisation: 27/05/2015,, Revision: 5, Authorised, Last updated: 10/07/2019
-
List item
Human medicine European public assessment report (EPAR): Zejula
Date of authorisation: 16/11/2017,, 
, Revision: 6, Authorised, Last updated: 21/10/2019
-
List item
Human medicine European public assessment report (EPAR): Caprelsa
Date of authorisation: 16/02/2012,, 
, Revision: 16, Authorised, Last updated: 05/11/2019
-
List item
Human medicine European public assessment report (EPAR): Farydak (updated)
Date of authorisation: 28/08/2015,, , Revision: 7, Authorised, Last updated: 02/12/2019
-
List item
Human medicine European public assessment report (EPAR): Tagrisso
Date of authorisation: 01/02/2016,, 
, Revision: 9, Authorised, Last updated: 23/10/2019
-
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA
Date of authorisation: 18/11/2014,, , , Revision: 9, Authorised, Last updated: 18/09/2019
-
List item
Human medicine European public assessment report (EPAR): Xofigo
Date of authorisation: 13/11/2013,
, , Revision: 10, Authorised, Last updated: 11/10/2018
-
List item
Human medicine European public assessment report (EPAR): Cabometyx
Date of authorisation: 09/09/2016,, , Revision: 6, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Yescarta
Date of authorisation: 23/08/2018,, , Revision: 2, Authorised, Last updated: 27/05/2019
-
List item
Human medicine European public assessment report (EPAR): Ristempa
Date of authorisation: 13/04/2015,, Revision: 3, Withdrawn, Last updated: 07/03/2018
-
List item
Human medicine European public assessment report (EPAR): Provenge
Date of authorisation: 06/09/2013,, Revision: 1, Withdrawn, Last updated: 19/05/2015
-
List item
Human medicine European public assessment report (EPAR): Alecensa
Date of authorisation: 16/02/2017,, Revision: 7, Authorised, Last updated: 14/09/2018
-
List item
Human medicine European public assessment report (EPAR): Portrazza
Date of authorisation: 15/02/2016,, Revision: 2, Authorised, Last updated: 05/12/2016